Sarepta (SRPT) Conditional-Approval Thesis Unchanged, Roth Capital Says

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. ABBV
7. DFTX
8. RGNX
9. GOOGL
10. LCO

Go back to Sarepta (SRPT) Conditional-Approval Thesis Unchanged, Roth Capital Says
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.74 +0.21 (1.20%)
Previous Close $17.53    52 Week High $63.73 
Open $17.82    52 Week Low $8.00 
Day High $18.00    P/E N/A 
Day Low $17.50    EPS $-5.69 
Volume 351,685